Method for treating intraocular neovascular diseases

Details for Australian Patent Application No. 2005299701 (hide)

International Classifications

Event Publications

26 April 2007 PCT application entered the National Phase

PCT publication WO2006/047325 Priority application(s): WO2006/047325

28 June 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 16 May 2007

17 November 2011 Application Accepted

Published as AU-B-2005299701

1 March 2012 Opposition Lodged

Bayer Pharma AG has lodged an opposition against Genentech, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.